共查询到20条相似文献，搜索用时 250 毫秒
1.
2.
为制备奶牛隐性乳房炎多价蜂胶灭活疫苗,研究多价蜂胶疫苗的免疫效果,试验将菌液用0.4%的甲醛灭活,以蜂胶作为佐剂,灭活菌液与蜂胶佐剂以1∶1的比例等体积混合制成多价蜂胶灭活疫苗,并对该疫苗的物理性质、安全性、免疫效果进行检测,通过构建小鼠模型设计浓度梯度,找出最佳免疫剂量。结果表明:通过攻毒试验,注射奶牛隐性乳房炎多价疫苗的混菌液,灭活疫苗的保护率达86.4%,免疫效果良好。说明制备的奶牛隐性乳房炎多价蜂胶灭活疫苗的混悬液具有良好的免疫保护效果。 相似文献
3.
大肠杆菌病目前只有大肠杆菌灭活疫苗。最好应用标准株加现地株的“现地自家多价灭活疫苗”,并且注意随时跟踪现地致病菌株的动态变化以便适时针锋相对,保证疫苗的“动态对型”预防。疫苗种类依佐剂的不同大体分为四类:铝胶佐剂灭活疫苗、蜂胶佐剂灭活疫苗、蜂胶中草药佐剂灭活疫苗、油佐剂灭活疫苗,以后二者效果最好。一般七日龄以上鸡均可应用,皮下或肌肉注射。禽霍乱分为灭活疫苗与弱毒活菌苗两大类,还有联苗和亚单位疫苗。1.灭活疫苗:共有“铝胶、油乳剂、蜂胶”3种佐剂类型,以蜂胶佐剂灭活苗保护率最高(80%以上)、免疫期最长(半年);铝… 相似文献
4.
利用4型禽腺病毒HLJ1701株进行灭活疫苗的研制,并对疫苗的免疫效果进行评价,为家禽4型禽腺病毒的防控提供数据及参考。将HLJ1701株用灭菌生理盐水作10~4倍稀释后,接种9日龄SPF鸡胚,37℃孵育72 h后收获感染鸡胚尿囊液,经甲醛灭活后,加白油佐剂乳化制成油乳剂灭活疫苗,对制备疫苗的性状、安全性、免疫效力等进行检验。结果显示,制备的3批4型禽腺病毒灭活疫苗(HLJ1701株)均为油包水型,黏度均在50 cP以内,对3批疫苗取样,样品经3000 r/min离心15 min,管底无水相析出。安全性试验结果显示,将疫苗按1 mL/只超剂量接种3周龄SPF鸡,试验鸡在观察期内全部健活,未出现局部或全身不良反应,表明疫苗对SPF鸡具有良好的安全性;免疫效力及攻毒保护试验结果显示,用疫苗按0.2 mL/只的剂量免疫接种3周龄SPF鸡1次,免疫接种后21d试验鸡血清中HLJ1701株的抗体平均效价可达2~8以上,使用4型禽腺病毒(HLJ1701株)接种0.2 mL/只(100 LD_(50))对免疫鸡进行攻毒,疫苗对免疫鸡的保护率均为100%。研究表明,实验室条件下研制的4型禽腺病毒(HLJ1701株)灭活疫苗的各项指标均符合标准。 相似文献
5.
6.
利用H7N9亚型重组禽流感病毒rGD76株进行灭活疫苗的研制,并对疫苗的免疫效果进行评价,为家禽H7N9亚型流感的防控提供科学数据及手段。将AIV-rGD76株用灭菌生理盐水作104倍稀释后,接种11日龄非免疫鸡胚,37℃孵育72h后收获感染鸡胚尿囊液,经甲醛灭活后,加矿物油佐剂乳化制成油乳剂灭活疫苗,对制备疫苗的性状、安全性、免疫效力等进行检验。结果显示,制备的3批重组禽流感病毒灭活疫苗(H7N9亚型,rGD76株)均为油包水型,黏度均在50cP以内,对3批疫苗取样,样品经3000r/min离心15min,管底无水相析出。安全性试验结果显示,将疫苗按1mL/只超剂量接种3周龄SPF鸡,试验鸡在观察期内全部健活,未出现局部或全身不良反应,表明疫苗对SPF鸡具有良好的安全性;免疫效力及攻毒保护试验结果显示,用疫苗按0.3mL/只的剂量免疫接种3周龄SPF鸡1次,免疫接种后21d试验鸡血清中rGD76株的HI抗体平均效价可达8log2以上,使用H7N9亚型高致病性禽流感病毒GD16株滴鼻接种0.2mL/只(含100LD50)对免疫鸡进行攻毒,疫苗对免疫鸡的保护率均为100%。在实验室条件下研制出重组禽流感病毒灭活疫苗(H7N9亚型,rGD76株),疫苗的各项指标均符合标准。 相似文献
7.
《中国家禽》2017,(17)
为研制鸡新城疫(ND)-传染性法氏囊病(IBD)-禽流感(AI,H9亚型)三联灭活疫苗,用新城疫病毒(NDV)La Sota株及H9亚型禽流感病毒(AIV)WD株分别接种易感鸡胚培养,用传染性法氏囊病病毒(IBDV)BJQ902株接种DF-1细胞培养,收获病毒液,经超滤浓缩、甲醛灭活后,加入油佐剂乳化制成3批疫苗。对3批制品进行了检验,其性状检验、装量检查、无菌检验、甲醛、汞类防腐剂残留量测定均符合要求,鸡对疫苗无任何不良反应。效力检验结果显示:ND部分以20μL/只剂量免疫,血凝抑制(HI)效价达5.6~6.1 log_2,攻毒后均能提供100%保护;IBD部分以0.5 mL/只剂量免疫,中和抗体效价达16.0~16.4 log_2,攻毒后均能提供100%保护;AI(H9亚型)部分以0.3 mL/只剂量免疫,HI效价达8.7~9.0 log_2,攻毒后均能提供100%保护。试验结果证实,研制的疫苗安全、免疫效力高。 相似文献
8.
为寻找更好的鸡大肠杆菌病多价蜂胶灭活疫苗的效检方法,本研究应用小白鼠代替本动物“鸡”,对鸡大肠杆菌病多价蜂胶灭活疫苗进行效检。结果表明,小白鼠免疫体重为18～22g,疫苗免疫剂量为0.3ml/只;免疫后10d,攻毒体重为20～28g,攻毒剂量为2～3×107CFU/只时,可代替本动物“鸡”对鸡大肠杆菌病多价蜂胶灭活疫苗进行效检,判定标准为免疫组8/10以上保护,对照组5/5死亡为合格。本效检方法可缩短检验期限7d,降低检验成本,具有更敏感、更特异、更客观、更简便等特点。 相似文献
9.
《中国兽医杂志》2014,(12)
68只豚鼠随机均分为4组,13组分别免疫蜂胶、铝胶和油佐剂PPV疫苗,第4组为空白对照组,注射等量生理盐水。免疫后不同时间点采集血清分析特异性血凝抑制抗体效价评价蜂胶佐剂对免疫豚鼠体液免疫的影响,测定淋巴细胞增殖、IL-2和IL-4含量评价蜂胶佐剂对免疫豚鼠细胞免疫的影响。结果表明,蜂胶、油佐剂和铝胶3种佐剂均能提高豚鼠对PPV灭活疫苗的免疫应答能力,油佐剂提高血清HI抗体效果较好,其次为蜂胶佐剂,再次为铝胶佐剂。蜂胶佐剂促进T淋巴细胞增殖和提高IL-2、IL-4、IL-6和IFN-γ含量效果优于油佐剂和铝胶佐剂。结论:蜂胶能增强PPV灭活疫苗的免疫效果。 相似文献
10.
为研究比较5种塞内卡病毒疫苗佐剂,分别用4种自主研发佐剂和进口ISA206佐剂配制塞内卡病毒灭活疫苗,检测疫苗的理化性质、安全性及免疫效力,并对检测结果进行对比分析。结果显示,进口ISA206佐剂疫苗黏度为43.02 cP,自主研发佐剂疫苗黏度均在27.88 cP以下,其他理化性质无差异;5批疫苗安全性试验均未见明显异常;5批疫苗免疫动物后均可诱导机体产生中和抗体,二免后14 d抗体滴度在211以上,4批自主研发佐剂疫苗免疫组抗体滴度水平高于进口ISA206佐剂疫苗约1个滴度,攻毒保护结果均在4/5以上,2批自主研发佐剂疫苗免疫组保护率可达5/5。结果表明,用4种自主研发佐剂制备的塞内卡病毒灭活疫苗质量不低于用进口ISA206佐剂制备的塞内卡病毒灭活疫苗。 相似文献
11.
The protective effect of an inactivated Mycoplasma gallisepticum (MG) bacterin was evaluated in chickens subsequently challenged intratracheally (IT) with the homologous strain. Antibody responses in sera and tracheal washings (TWs) from these chickens were determined by an enzyme-linked immunosorbent assay. A group of chickens was vaccinated intramuscularly (IM) with two doses of the bacterin containing aluminum hydroxide gel (IM + IM). Another group was vaccinated IM with the same bacterin followed by IT with bacterin lacking the adjuvant (IM + IT). Chickens of both vaccinated groups had similar levels of antibody in TWs at the time of challenge. MG was eliminated from the trachea at higher rates and inflammatory lesions in the trachea were less severe in vaccinated chickens than in unvaccinated controls. The protective effect in chickens vaccinated IM + IT was greater than that in chickens vaccinated IM + IM. Perhaps vaccinal immunity is mediated by local rather than systemic antibody responses, or perhaps resistance provided by vaccination IM + IT is conferred partly by another immune mechanism such as cell-mediated immunity. 相似文献
12.
One-week-old chickens were vaccinated with commercial Mycoplasma gallisepticum bacterin subcutaneously and challenged with the S6 strain by the intra-air-sac route 3 weeks later. Significantly fewer vaccinated chickens had air-sac lesions than controls. 相似文献
13.
The serological response and protective immunity elicited in the chicken by the pathogenic Ap3AS strain and the moderately pathogenic 80083 strain of Mycoplasma gallisepticum and variants of strain 80083 attenuated by repeated passage in mycoplasma broth were investigated. Strain 80083 elicited a substantial serum antibody response after administration either in drinking water or by conjunctival sac instillation to 7-week-old SPF chickens. No vaccinated chickens developed air sac lesions when challenged by intra-abdominal (IA) injection with the virulent Ap3AS strain. Chickens vaccinated with strain 80083M (50 broth passages) showed only a weak serological response but were substantially protected when challenged 4 weeks after vaccination. Chickens vaccinated with 80083H (100 broth passages) were serologically negative 4 weeks after vaccination and developed severe air sac lesions after challenge. Thirty-seven-week-old hens vaccinated 6 months previously with strain 80083 had high serum antibody levels and were completely protected against IA challenge with the homologous strain. However, 4/6 showed mild air sac lesions when challenged intra-abdominally with strain Ap3AS. Another group showed high M. gallisepticum serum antibody levels 6 months after vaccination with strain Ap3AS but 4/6 and 2/6 showed mild lesions after IA challenge with strains Ap3AS or 80083, respectively. Strains 80083 or 80083M were administered by conjunctival sac instillation to susceptible 11-week-old commercial pullets at the time of fowl pox vaccination. The concurrent use of both vaccines had no apparent adverse effect on the health of the chickens. Similar protection against IA challenge with strain Ap3AS was produced with the M. gallisepticum vaccines whether used alone or in combination with fowl pox. 相似文献
14.
Mycoplasma gallisepticum vaccination: effects on egg transmission and egg production 总被引：1，自引：0，他引：1
The effects of Mycoplasma gallisepticum (MG) vaccination on egg transmission of MG and egg production were evaluated. Leghorn hens vaccinated with live MG (strain F), with strain F plus MG bacterin, with one dose of MG bacterin, or with two doses of MG bacterin all transmitted MG through the egg at a significantly lower level than unvaccinated controls. Hens vaccinated with two doses of MG bacterin had the longest lag before detectable transmission of MG through the egg. All vaccinated groups were protected against the egg-production drop seen in unvaccinated hens challenged with virulent MG. 相似文献
15.
A commercially available inactivated Mycoplasma gallisepticum (MG) bacterin was administered to chickens on a multiple-age farm endemically infected with MG. A total of 3400 MG-free pullets were vaccinated with the MG bacterin at 19 weeks of age, and 4300 unvaccinated pullets served as controls. The vaccinated group became serologically positive by the rapid plate agglutination (RPA) test within 3 weeks, and the unvaccinated group became positive in 7 weeks. The hemagglutination-inhibition test responses were observed at approximately the same time as the RPA in both of the groups. Egg production and mortality through 50 weeks of age did not differ significantly between the two groups. MG was isolated from birds of the vaccinated and control groups near the termination of the study. 相似文献
16.
Avian intestinal spirochaetosis (AIS) is a disease complex affecting adult laying and breeding chickens associated with infection by anaerobic intestinal spirochaetes of the genus Brachyspira. Options for control of AIS are limited, as few effective antimicrobial agents are registered for use in laying chickens. One of the two most commonly encountered pathogenic species in AIS is B. intermedia, and the aim of the current study was to determine whether a B. intermedia bacterin vaccine would help control AIS caused by this species. An autogenous bacterin was prepared from B. intermedia strain HB60 and given twice intramuscularly at a 3-week interval to 12 laying chickens housed in individual cages. Twelve non-vaccinated control chickens were placed in adjacent cages in the same room. Two weeks after the second vaccination all the chickens were experimentally challenged with B. intermedia HB60 by crop tube. Subsequently faeces were cultured for spirochaetes every 2-3 days, faecal water content and chicken weight were measured weekly, and egg numbers and weights were recorded daily. Serum was taken prior to both vaccinations, at the time of challenge and at euthanasia. The chickens were killed 6 weeks post-challenge. The vaccinated chickens showed seroconversion to the vaccine, but antibody levels declined significantly post-infection. In comparison, the non-vaccinated chickens showed seroconversion post-infection. The reason for the reduction in the antibody levels in the vaccinated chickens after infection was not explained. At some point all the chickens excreted spirochaetes in their faeces, and the duration of excretion was not different between vaccinated and non-vaccinated chickens. There were no differences in faecal water content, chicken weights, egg production, or gross and microscopic caecal lesions between vaccinated and non-vaccinated chickens. In conclusion, an autogenous bacterin vaccine did not prevent infection with B. intermedia in laying chickens. 相似文献
17.
Nonspecific reactions to Mycoplasma meleagridis (MM) and M. gallisepticum antigens were found in the sera of turkeys vaccinated with Erysipelothrix insidiosa (EI) bacterin, but they could be removed by adsorption with EI bacterin. True reactions to MM could not be so removed. 相似文献
18.
The efficacy of three commercial Mycoplasma gallisepticum (MG) immunizing agents-a bacterin, a recombinant fowlpox-MG vaccine, and a live F-strain vaccine-was compared in specific-pathogen-free hens in egg production. Three groups of 25 chickens were vaccinated with one of the vaccines at 10 wk of age and 25 birds were not vaccinated. At 25 wk of age (and approximately 50% egg production), 20 birds from each of the three vaccinated groups and 15 nonvaccinated controls were challenged with virulent R-strain via aerosol; the birds were necropsied and evaluated at 10 days post-challenge. The MG bacterin and live F-strain vaccinations were both protective and resulted in significant differences in air sac lesions, tracheal lesions, and ovarian regression compared to the nonvaccinated controls and the recombinant fowlpox-MG vaccine (P < or = 0.05). The evaluation of ovarian regression is a useful method of testing the efficacy of MG vaccines in laying hens. 相似文献
19.
The immunogenicity of the ts-11 vaccine strain of Mycoplasma gallisepticum was assessed following eye drop or coarse aerosol administration in chickens of various ages. Protection was evalualted following intra-abdominal (IA) or fine droplet aerosol administration of virulent M. gallisepticum, usually the Ap3AS strain and was measured mainly by the scoring of gross air sac lesions or by egg production. Vaccination of chickens with ts-11 did not elicit a substantial serum antibody response as measured by rapid serum agglutination test, or ELISA. Protection was never demonstrated when no M. gallisepticum serum antibody response was detected in a vaccinated group of chickens. Failure to protect occurred usually, although not invariably, following aerosol administration of the vaccine. Vaccination by eye drop usually, although not invariably provided protection against challenge. In one experiment, chickens vaccinated by eye drop at 8-weeks were as susceptible as non vaccinated controls when challenged by IA inoculation at 13-weeks-of-age. Yet other birds from the same vaccinated group were resistant when challenged in an identical way at 23-weeks. No measurable increase in M. gallisepticum specific serum antibody concentrations occurred in the intervening period. Equally surprising was the response of another group of birds in the same experiment that had been vaccinated with a higher dose of ts-11. An antibody response was detected in this group, but they were susceptible to challenge at 23-weeks. Interestingly, a drop in egg production commenced 4 weeks after challenge, 2 weeks later than that observed in a non vaccinated group challenged at the same time.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
20.
The effect of oil-emulsion vaccines on the occurrence of nonspecific plate agglutination reactions for Mycoplasma gallisepticum and M. synoviae 总被引：1，自引：0，他引：1
Six groups of ten 18-week-old mycoplasma-free white leghorn pullets were vaccinated with one of the following: Mycoplasma gallisepticum (MG) bacterin. Haemophilus gallinarum bacterin, Pasteurella multocida bacterin, combined infectious bursal disease (IBD)-Newcastle (NDV) chicken-embryo-origin (CEO) vaccine. IBD-NDV tissue-culture-origin (TC) vaccine, or saline emulsified in oil; one group received no vaccine. Plate agglutination tests for M. synoviae (MS) and MG were done for 10 weeks after vaccination using three different test antigens. Pullets vaccinated with H. gallinarum bacterin and IBD-NDV TC vaccine showed the greatest incidence of nonspecific plate agglutination reactions. The incidence of positive plate agglutination reactions varied with test antigens. Five groups of fifty 18-week-old mycoplasma-free heavy-breed pullets were vaccinated with one of the following: saline emulsified in oil, chicken embryo fibroblasts emulsified in oil, allantoic fluid emulsified in oil, chicken embryos emulsified in oil, or MS-contaminated chicken embryos emulsified in oil. Plate agglutination tests for MS and MG were done for 8 weeks after vaccination. Chickens vaccinated with chicken embryo fibroblasts emulsified in oil had the greatest incidence of nonspecific plate agglutination reactions. Pullets vaccinated with MS-contaminated chicken embryo vaccine had only a small increase in MS-positive plate agglutination reactions compared with pullets vaccinated with uncontaminated chicken embryo vaccine. 相似文献